PURPOSE: We evaluated the ability of 2-deoxy-2-(18)F-fluoro-D-glucose (FDG) positron emission tomography (PET) in the early assessment of therapeutic response in patients with small cell lung cancer (SCLC). PROCEDURES: FDG PET studies were performed before (baseline PET), after the first cycle of chemotherapy (early PET), and after completion of therapy (final PET) in 12 patients with SCLC. The standardized uptake value (SUVmax) was measured. Metabolic response was defined as a reduction in SUVmax of more than 20% on the early PET, compared with the baseline PET. Tumor response after completion of therapy was evaluated according to the Response Evaluation Criteria in Solid Tumors (RECIST). RESULTS: Eleven patients were classified as metabolic responders and had a mean (+/-SD) reduction in SUVmax of 57.9 +/- 10.3%. The remaining one patient was classified as a metabolic nonresponder with a reduction in SUVmax of 13.5%. In all patients, metabolic response after the first cycle of chemotherapy was associated with subsequent response according to RECIST. CONCLUSIONS: FDG PET has the potential to identify the therapeutic response in patients with SCLC as early as after the first cycle of chemotherapy.
PURPOSE: We evaluated the ability of 2-deoxy-2-(18)F-fluoro-D-glucose (FDG) positron emission tomography (PET) in the early assessment of therapeutic response in patients with small cell lung cancer (SCLC). PROCEDURES: FDG PET studies were performed before (baseline PET), after the first cycle of chemotherapy (early PET), and after completion of therapy (final PET) in 12 patients with SCLC. The standardized uptake value (SUVmax) was measured. Metabolic response was defined as a reduction in SUVmax of more than 20% on the early PET, compared with the baseline PET. Tumor response after completion of therapy was evaluated according to the Response Evaluation Criteria in Solid Tumors (RECIST). RESULTS: Eleven patients were classified as metabolic responders and had a mean (+/-SD) reduction in SUVmax of 57.9 +/- 10.3%. The remaining one patient was classified as a metabolic nonresponder with a reduction in SUVmax of 13.5%. In all patients, metabolic response after the first cycle of chemotherapy was associated with subsequent response according to RECIST. CONCLUSIONS: FDG PET has the potential to identify the therapeutic response in patients with SCLC as early as after the first cycle of chemotherapy.
Authors: P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther Journal: J Natl Cancer Inst Date: 2000-02-02 Impact factor: 13.506
Authors: V W Rusch; D J Giroux; M J Kraut; J Crowley; M Hazuka; D Johnson; M Goldberg; F Detterbeck; F Shepherd; R Burkes; T Winton; C Deschamps; R Livingston; D Gandara Journal: J Thorac Cardiovasc Surg Date: 2001-03 Impact factor: 5.209
Authors: Hinrich A Wieder; Ambros J Beer; Florian Lordick; Katja Ott; Michael Fischer; Ernst J Rummeny; Sibylle Ziegler; Jörg R Siewer; Markus Schwaiger; Wolfgang A Weber Journal: J Nucl Med Date: 2005-12 Impact factor: 10.057
Authors: H Young; R Baum; U Cremerius; K Herholz; O Hoekstra; A A Lammertsma; J Pruim; P Price Journal: Eur J Cancer Date: 1999-12 Impact factor: 9.162
Authors: Robert Chin; Trent W McCain; Antonius A Miller; Donnie P Dunagan; Jose Acostamadiedo; L Douglas Case; Beth A Harkness; Lee P Adler; Edward F Haponik Journal: Lung Cancer Date: 2002-07 Impact factor: 5.705
Authors: Judith van Loon; Claudia Offermann; Michel Ollers; Wouter van Elmpt; Erik Vegt; Ali Rahmy; Anne-Marie C Dingemans; Philippe Lambin; Dirk De Ruysscher Journal: Radiother Oncol Date: 2011-05-14 Impact factor: 6.280
Authors: Eduardo H Moriyama; Weiguo Cao; Tracy W Liu; Han Lin Wang; Peter D Kim; Juan Chen; Gang Zheng; Brian C Wilson Journal: Mol Imaging Biol Date: 2014-08 Impact factor: 3.488
Authors: Paul Flechsig; Clemens Kratochwil; Arne Warth; Daniel Rath; Viktoria Eichwald; Peter E Huber; Hans-Ulrich Kauczor; Uwe Haberkorn; Frederik L Giesel Journal: Mol Imaging Biol Date: 2016-04 Impact factor: 3.488